187 related articles for article (PubMed ID: 14726414)
1. Clinical significance of small dense low-density lipoprotein cholesterol levels determined by the simple precipitation method.
Hirano T; Ito Y; Koba S; Toyoda M; Ikejiri A; Saegusa H; Yamazaki J; Yoshino G
Arterioscler Thromb Vasc Biol; 2004 Mar; 24(3):558-63. PubMed ID: 14726414
[TBL] [Abstract][Full Text] [Related]
2. Application of a modified precipitation method for the measurement of small dense LDL-cholesterol (sd-LDL-C) in a population in southern Brazil.
Cavalcante Lda S; da Silva EL
Clin Chem Lab Med; 2012 Mar; 50(9):1649-56. PubMed ID: 22962227
[TBL] [Abstract][Full Text] [Related]
3. Comparison of a homogeneous assay with a precipitation method for the measurement of HDL cholesterol in diabetic patients.
Jensen T; Truong Q; Frandsen M; Dinesen B; Stender S
Diabetes Care; 2002 Nov; 25(11):1914-8. PubMed ID: 12401732
[TBL] [Abstract][Full Text] [Related]
4. Remarkably high prevalence of small dense low-density lipoprotein in Japanese men with coronary artery disease, irrespective of the presence of diabetes.
Koba S; Hirano T; Yoshino G; Sakai K; Sakaue T; Adachi M; Katagiri T
Atherosclerosis; 2002 Jan; 160(1):249-56. PubMed ID: 11755944
[TBL] [Abstract][Full Text] [Related]
5. [Metabolic syndrome and small dense LDL-cholesterol].
Hirano T
Rinsho Byori; 2007 May; 55(5):434-8. PubMed ID: 17593688
[TBL] [Abstract][Full Text] [Related]
6. Method for estimating high sdLDL-C by measuring triglyceride and apolipoprotein B levels.
Hayashi T; Koba S; Ito Y; Hirano T
Lipids Health Dis; 2017 Jan; 16(1):21. PubMed ID: 28125987
[TBL] [Abstract][Full Text] [Related]
7. Peroxisome proliferator-activated receptor-gamma agonist increases both low-density lipoprotein cholesterol particle size and small high-density lipoprotein cholesterol in patients with type 2 diabetes independent of diabetic control.
Bavirti S; Ghanaat F; Tayek JA
Endocr Pract; 2003; 9(6):487-93. PubMed ID: 14715475
[TBL] [Abstract][Full Text] [Related]
8. Intensive insulin therapy reduces small dense low-density lipoprotein particles in patients with type 2 diabetes mellitus: relationship to triglyceride-rich lipoprotein subspecies.
Hayashi T; Hirano T; Yamamoto T; Ito Y; Adachi M
Metabolism; 2006 Jul; 55(7):879-84. PubMed ID: 16784958
[TBL] [Abstract][Full Text] [Related]
9. Association of small dense lowdensity lipoprotein cholesterol in type 2 diabetics with coronary artery disease.
Huang YC; Chang PY; Hwang JS; Ning HC
Biomed J; 2014; 37(6):375-9. PubMed ID: 25179702
[TBL] [Abstract][Full Text] [Related]
10. Reference values assessment in a Mediterranean population for small dense low-density lipoprotein concentration isolated by an optimized precipitation method.
Fernández-Cidón B; Padró-Miquel A; Alía-Ramos P; Castro-Castro MJ; Fanlo-Maresma M; Dot-Bach D; Valero-Politi J; Pintó-Sala X; Candás-Estébanez B
Vasc Health Risk Manag; 2017; 13():201-207. PubMed ID: 28652759
[TBL] [Abstract][Full Text] [Related]
11. Triglyceride/low-density-lipoprotein cholesterol ratio is the most valuable predictor for increased small, dense LDL in type 2 diabetes patients.
Ouchi G; Komiya I; Taira S; Wakugami T; Ohya Y
Lipids Health Dis; 2022 Jan; 21(1):4. PubMed ID: 34996463
[TBL] [Abstract][Full Text] [Related]
12. Pathophysiology of Diabetic Dyslipidemia.
Hirano T
J Atheroscler Thromb; 2018 Sep; 25(9):771-782. PubMed ID: 29998913
[TBL] [Abstract][Full Text] [Related]
13. Effects of atorvastatin versus fenofibrate on lipoprotein profiles, low-density lipoprotein subfraction distribution, and hemorheologic parameters in type 2 diabetes mellitus with mixed hyperlipoproteinemia.
Frost RJ; Otto C; Geiss HC; Schwandt P; Parhofer KG
Am J Cardiol; 2001 Jan; 87(1):44-8. PubMed ID: 11137832
[TBL] [Abstract][Full Text] [Related]
14. N-3 polyunsaturated fatty acids improve lipoprotein particle size and concentration in Japanese patients with type 2 diabetes and hypertriglyceridemia: a pilot study.
Ide K; Koshizaka M; Tokuyama H; Tokuyama T; Ishikawa T; Maezawa Y; Takemoto M; Yokote K
Lipids Health Dis; 2018 Mar; 17(1):51. PubMed ID: 29544483
[TBL] [Abstract][Full Text] [Related]
15. Distribution of LDL subgroups in patients with hyperlipidemia.
Taylan E; Tuncel EP
Turk J Med Sci; 2016 Feb; 46(2):374-80. PubMed ID: 27511499
[TBL] [Abstract][Full Text] [Related]
16. Atherogenic role of elevated CE transfer from HDL to VLDL(1) and dense LDL in type 2 diabetes : impact of the degree of triglyceridemia.
Guérin M; Le Goff W; Lassel TS; Van Tol A; Steiner G; Chapman MJ
Arterioscler Thromb Vasc Biol; 2001 Feb; 21(2):282-8. PubMed ID: 11156866
[TBL] [Abstract][Full Text] [Related]
17. HDL subfractions analysis: a new laboratory diagnostic assay for patients with cardiovascular diseases and dyslipoproteinemia.
Oravec S; Dostal E; Dukát A; Gavorník P; Kucera M; Gruber K
Neuro Endocrinol Lett; 2011; 32(4):502-9. PubMed ID: 21876506
[TBL] [Abstract][Full Text] [Related]
18. Association of small dense LDL with coronary artery disease and diabetes in urban Asian Indians - the Chennai Urban Rural Epidemiology Study (CURES-8).
Mohan V; Deepa R; Velmurugan K; Gokulakrishnan K
J Assoc Physicians India; 2005 Feb; 53():95-100. PubMed ID: 15847025
[TBL] [Abstract][Full Text] [Related]
19. Changes in plasma lipid and apolipoprotein levels between heparin-induced extracorporeal low-density lipoprotein precipitation (HELP) treatments.
Lane DM; Alaupovic P; Knight-Gibson C; Dudley VS; Laughlin LO
Am J Cardiol; 1995 Jun; 75(16):1124-9. PubMed ID: 7762498
[TBL] [Abstract][Full Text] [Related]
20. Lipoprotein profile in patients who survive a stroke.
Oravec S; Krivosikova Z; Krivosik M; Gruber K; Gruber M; Dukát A; Gavorník P
Neuro Endocrinol Lett; 2011; 32(4):496-501. PubMed ID: 21876499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
